New version – corrected 17 September, 2020 The results of Enzymatica's placebo-controlled, randomized study
Enzymatica distributed the press release about the result from its placebo-controlled, randomized study in Germany on August 17th. In this version the company referred incorrectly in the quote by Claus Egstrand that the results from the study confirmed that ColdZyme fulfilled the Cochrane criteria for evidence-based documentation. In the corrected version as of today the company has removed the reference to Cochrane and modified the quote according to what is stated below. Besides this nothing in the press release has changed, which means that the results from the study are still as valid.